Eton Pharmaceutcials Inc (ETON) Stock Price, Quote & News

Company Profile

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developi...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 847 787 7361

Website: www.etonpharma.com

Address:

21925 W. Field Parkway, Suite 235, Deer Park, United States

badgermobile Oct. 22 at 1:15 PM

$ETON AVDL acquired today, I think bios like ETON undervalued will have a great q4, rates dropping and profitable could hit 24-25 by q1 with a solid Q3 report and new drug approval

0 · Reply

RunsWithDogs Oct. 17 at 5:22 PM

$ETON Barring another overall market meltdown, I'm going out on a limb to say I wouldn't expect to see anything below $17.50 again. We should begin to see anticipation for Q3 earnings during the next week or two. I'm thinking we should be back above $20 very soon. Someday, some larger funds are going to notice our increasing profit potential and we won't ever see teens again. I'm very

2 · Reply

Doozio Oct. 14 at 5:25 PM

$MNND is riding them huckleberries excited TTWO da $SOUN d of turnaround tuesday ready to be $ETON then again 🐒🍌🧠⏰♾️

0 · Reply

Tennis_4567 Oct. 13 at 9:20 PM

$ETON hopefully that wasn’t Sean selling again 😆

1 · Reply

bryantboy99 Oct. 6 at 3:15 PM

$ETON crazy to think there's only 5600 watchers on here.

0 · Reply

A_Train1 Oct. 1 at 7:57 PM

$ETON gave back 7% - seems like a lot

0 · Reply

RunsWithDogs Oct. 1 at 4:45 PM

$ETON Well, that 21.27 gap is filled to say the least. The market makers overachieved but it is coming back up. Let's see some green!

0 · Reply

RunsWithDogs Sep. 30 at 6:54 PM

$ETON Hope I'm wrong, but could this be wiggling down to that 21.27 gap I referenced yesterday? Disappointing, considering it made another 52 week high today just under $23.

1 · Reply

Doozio Sep. 30 at 6:29 PM

How? It’s $ETON all the $DRUG zzzzzz 🐒🍌🧠⏰♾️. Don’t od DAVE still gotta get NUTX!! 2020FIF

0 · Reply

bryantboy99 Sep. 30 at 12:13 PM

$ETON Today?

1 · Reply

Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Aug 20, 2025, 6:50 AM EDT - 2 months ago

Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference

Aug 8, 2025, 3:27 PM EDT - 2 months ago

Eton Pharmaceuticals, Inc. (ETON) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 5:02 AM EDT - 2 months ago

Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options

Aug 7, 2025, 4:05 PM EDT - 2 months ago

Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results

Jul 28, 2025, 7:00 AM EDT - 3 months ago

Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Jul 15, 2025, 9:33 AM EDT - 3 months ago

Eton Pharma Near Term Catalysts Vanish

Jul 8, 2025, 6:50 AM EDT - 3 months ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

Jun 27, 2025, 6:50 AM EDT - 4 months ago

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

Jun 6, 2025, 5:26 PM EDT - 5 months ago

Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside

May 29, 2025, 12:42 PM EDT - 5 months ago

FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue

May 28, 2025, 5:28 PM EDT - 5 months ago

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

May 21, 2025, 2:57 AM EDT - 5 months ago

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche

May 14, 2025, 4:30 PM EDT - 5 months ago

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

May 13, 2025, 10:40 PM EDT - 5 months ago

Eton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:01 PM EDT - 5 months ago

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

May 1, 2025, 4:30 PM EDT - 6 months ago

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Apr 28, 2025, 6:50 AM EDT - 6 months ago

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

Apr 1, 2025, 7:00 AM EDT - 7 months ago

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

Mar 25, 2025, 2:30 AM EDT - 7 months ago

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program

Mar 18, 2025, 7:42 PM EDT - 7 months ago

Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call Transcript

Mar 18, 2025, 6:50 AM EDT - 7 months ago

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

Mar 14, 2025, 6:50 AM EDT - 8 months ago

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Mar 4, 2025, 10:00 AM EST - 8 months ago

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®

Mar 4, 2025, 6:50 AM EST - 8 months ago

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

Mar 3, 2025, 6:50 AM EST - 8 months ago

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

Feb 7, 2025, 6:50 AM EST - 9 months ago

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

Feb 6, 2025, 6:50 AM EST - 9 months ago

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

Jan 3, 2025, 6:50 AM EST - 10 months ago

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

Dec 20, 2024, 6:50 AM EST - 11 months ago

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Dec 3, 2024, 6:50 AM EST - 11 months ago

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

Nov 25, 2024, 6:50 AM EST - 11 months ago

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Nov 12, 2024, 8:01 PM EST - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:01 PM EST - 1 year ago

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:30 PM EST - 1 year ago

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Oct 3, 2024, 6:30 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

Aug 22, 2024, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 11, 2024, 8:15 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 5:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Jul 15, 2024, 4:05 PM EDT - 1 year ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

May 11, 2024, 9:34 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript

May 9, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

May 1, 2024, 4:05 PM EDT - 1 year ago

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

Apr 30, 2024, 7:00 AM EDT - 1 year ago

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Apr 29, 2024, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Mar 22, 2024, 2:20 AM EDT - 1 year ago

Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE

Mar 22, 2024, 2:00 AM EDT - 1 year ago

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

Mar 14, 2024, 9:38 PM EDT - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

badgermobile Oct. 22 at 1:15 PM

$ETON AVDL acquired today, I think bios like ETON undervalued will have a great q4, rates dropping and profitable could hit 24-25 by q1 with a solid Q3 report and new drug approval

0 · Reply

RunsWithDogs Oct. 17 at 5:22 PM

2 · Reply

Doozio Oct. 14 at 5:25 PM

$MNND is riding them huckleberries excited TTWO da $SOUN d of turnaround tuesday ready to be $ETON then again 🐒🍌🧠⏰♾️

0 · Reply

Tennis_4567 Oct. 13 at 9:20 PM

$ETON hopefully that wasn’t Sean selling again 😆

1 · Reply

bryantboy99 Oct. 6 at 3:15 PM

$ETON crazy to think there's only 5600 watchers on here.

0 · Reply

A_Train1 Oct. 1 at 7:57 PM

$ETON gave back 7% - seems like a lot

0 · Reply

RunsWithDogs Oct. 1 at 4:45 PM

$ETON Well, that 21.27 gap is filled to say the least. The market makers overachieved but it is coming back up. Let's see some green!

0 · Reply

RunsWithDogs Sep. 30 at 6:54 PM

$ETON Hope I'm wrong, but could this be wiggling down to that 21.27 gap I referenced yesterday? Disappointing, considering it made another 52 week high today just under $23.

1 · Reply

Doozio Sep. 30 at 6:29 PM

How? It’s $ETON all the $DRUG zzzzzz 🐒🍌🧠⏰♾️. Don’t od DAVE still gotta get NUTX!! 2020FIF

0 · Reply

bryantboy99 Sep. 30 at 12:13 PM

$ETON Today?

1 · Reply

Doozio Sep. 29 at 11:12 PM

$ETON MLYS to 🐒🍌🧠⏰♾️ BILIs.

0 · Reply

Doozio Sep. 29 at 5:10 PM

$ETON appears like it’s going from MLYS TTWO BILI’s during 🐒🍌🧠⏰♾️

0 · Reply

bryantboy99 Sep. 29 at 3:41 PM

$ETON LFG!!!!!!

0 · Reply

RunsWithDogs Sep. 29 at 2:32 PM

$ETON New 52 week high, which is indeed bullish! That said, it did leave a gap this morning that will probably be filled in the next several days, so don’t be surprised if it comes back down to 21.27. I think it will be a quick test and up again. Strength is phenomenal, even on low volume! Imagine if we get news or new whales investing…

0 · Reply

FFGarcia Sep. 29 at 12:37 AM

$ETON Very bullish; sitting right close to the all-time high/resistance. It just has to break past 21.48 to fly to the moon. Estimated upside target is 24.

0 · Reply

bryantboy99 Sep. 26 at 7:20 PM

$ETON new ATH coming today?

1 · Reply

Doozio Sep. 26 at 6:29 PM

$TSLA 🦄👑 getting ready to walk into the weekend $ETON those huckleberries like they are the $QURE to the 🐑 to turn those $GRRR s into BILI’s during 🐒🍌🧠⏰♾️ ❤️👑🌈🦄

1 · Reply

SpyVsSpy2 Sep. 26 at 6:13 PM

$ETON 21

0 · Reply

Doozio Sep. 26 at 1:04 AM

They said it only matter if wen YO $ETON da huckleberries they ride. During 🐒🍌🧠⏰♾️

1 · Reply

TradeHuntFish Sep. 24 at 2:35 PM

XPON is in the perfect storm: ✔️ Former runner ✔️ Micro float ✔️ Chart base forming ✔️ Lithium theme reloading You don’t want to chase after the move this is the load zone. $PRST $DUO $ETON $PGY $TSAT

0 · Reply

TradeHuntFish Sep. 24 at 10:57 AM

XPON isn’t just another microcap it’s a bottomed energy tech play with a real growth narrative. Lithium. Clean storage. Market-ready products. One PR and this goes parabolic. $GTII $ETON $OPEN $GME …

0 · Reply

bryantboy99 Sep. 23 at 8:01 PM

$ETON whew, glad i didn't sell after Leslie told us to avoid this stock.

1 · Reply

Market Cap	495.06M
Revenue (ttm)	39.01M
Net Income (ttm)	-3.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	62.85
Profit Margin	-9.79%
Debt to Equity Ratio	1.26

Volume	145,400
Avg Vol	290,488
Day's Range	N/A - N/A
Shares Out	26.82M
Stochastic %K	50%
Beta	1.16
Analysts	Strong Sell
Price Target	$29.67